These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4173212)
1. [Immunologic study of human prothrombin and thrombin]. Josso F; Lavergne JM; Weilland C; Soulier JP Thromb Diath Haemorrh; 1967 Dec; 18(3-4):311-24. PubMed ID: 4173212 [No Abstract] [Full Text] [Related]
2. The purification of human factor II (prothrombin) and the preparation of a specific antiserum. Heystek J; Maier van den Zande GM; Brummelhuis HG; Krijnen HW Vox Sang; 1974; 27(3):214-26. PubMed ID: 4213473 [No Abstract] [Full Text] [Related]
3. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing. Pechet L; Smith JA Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341 [No Abstract] [Full Text] [Related]
4. Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease. Largo R; Sigg P; von Felten A; Straub PW Br J Haematol; 1974 Jan; 26(1):129-40. PubMed ID: 4211775 [No Abstract] [Full Text] [Related]
5. Characterization and experimental use of a monospecific antiserum to factor IX. Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483 [TBL] [Abstract][Full Text] [Related]
6. Tentative immunochemical analysis of the prothrombin molecule. Lavergne JM; Weilland C; Josso F Pathol Biol (Paris); 1972 Dec; ():Suppl:47-51. PubMed ID: 4122342 [No Abstract] [Full Text] [Related]
7. Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona. Josso F; Monasterio de Sanchez J; Lavergne JM; Menache D; Soulier JP Blood; 1971 Jul; 38(1):9-16. PubMed ID: 4997605 [No Abstract] [Full Text] [Related]
9. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety. Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288 [TBL] [Abstract][Full Text] [Related]
10. [Effect of prothrombin and fibrinogen antisera on the clotting system of bovine blood]. Kotschy M Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):426-36. PubMed ID: 4121336 [No Abstract] [Full Text] [Related]
11. [Effect of nitro-- derivatives of warfarin on blood coagulation]. Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901 [No Abstract] [Full Text] [Related]
16. [Efficiency and limits of immunologic methods in the diagnosis of blood coagulation]. Schwick HG; Trobisch H; Heimburger N Internist (Berl); 1973 Apr; 14(4):160-9. PubMed ID: 4197663 [No Abstract] [Full Text] [Related]
17. [The physiology of blood platelets]. Lüscher EF Schweiz Med Wochenschr; 1968 Oct; 98(42):1629-35. PubMed ID: 5698340 [No Abstract] [Full Text] [Related]
18. Immunologic properties of factor IX (Christmas factor). Uszyński L Arch Immunol Ther Exp (Warsz); 1969; 17(3):320-31. PubMed ID: 5802831 [No Abstract] [Full Text] [Related]
19. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man. DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053 [No Abstract] [Full Text] [Related]